NCT06247631 STOP-Bang Questionnaire: A Predictor of Obstructive Sleep Apnea and Difficult Mask/Intubation?
| NCT ID | NCT06247631 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Atatürk Chest Diseases and Chest Surgery Training and Research Hospital |
| Condition | Difficult Intubation |
| Study Type | OBSERVATIONAL |
| Enrollment | 125 participants |
| Start Date | 2024-01-10 |
| Primary Completion | 2025-12-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 125 participants in total. It began in 2024-01-10 with a primary completion date of 2025-12-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Difficult airway management remains the leading cause of anaesthesia-related morbidity and mortality. Obstructive sleep apnea syndrome (OSAS) is a warning sign of difficult airway management. Polysomnography is the gold standard for diagnosis of this syndrome, but the STOP-BANG questionnaire is the preferred screening test. In this study, we wanted to find an answer to the question How successful is the STOP-BANG questionnaire in screening for obstructive sleep apnea syndrome (OSAS) in predicting OSAS, difficult mask and difficult intubation in patients undergoing thoracic surgery?
Eligibility Criteria
Inclusion Criteria: * Patient undergoing thoracic surgery * 18-65 years old * ASA 1-3 Exclusion Criteria: * Having a history of obstructive sleep apnea syndrome, * Having a history of previous head and neck surgery/radiotherapy, * Patients who did not agree to participate in the study
Contact & Investigator
Ali ALAGÖZ, professor
PRINCIPAL INVESTIGATOR
Ankara Ataturk Sanatorium Training and Research Hospital
Frequently Asked Questions
Who can join the NCT06247631 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Difficult Intubation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06247631 currently recruiting?
Yes, NCT06247631 is actively recruiting participants. Contact the research team at mdalagoz@gmail.com for enrollment information.
Where is the NCT06247631 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06247631 clinical trial?
NCT06247631 is sponsored by Atatürk Chest Diseases and Chest Surgery Training and Research Hospital. The principal investigator is Ali ALAGÖZ, professor at Ankara Ataturk Sanatorium Training and Research Hospital. The trial plans to enroll 125 participants.